Skip to main content
. 2005 Oct;54(10):1428–1436. doi: 10.1136/gut.2004.046946

Table 2.

 Expression of surface markers on CD4+CD62L+ cells detected by flow cytometric analysis

Treatment of mice None CpG-ODN GpG-ODN (control)
CD25 13.8 14.6 15.5
αEβ7 9.8 5.7 6.6
GITR 5.8 5.1 7.3
CTLA-4 0.4 0.6 0.4

Results are given as positive cells (in per cent) and are representative of three independent experiments.

CpG-ODN, cytosin-guanosin containing oligodeoxynucleotide.